Evidence map›Paper›PMID 34967575›Full record

Trial reportAsian Pacific journal of cancer prevention : APJCP2021

Black Turmeric and Aloe Vera in the Management of Oral Submucous Fibrosis: A Prospective Clinical Study.

Ankita Bohra, T N Uma Maheswari, Aditya Harsh, Ayush Garg

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Asian Pacific journal of cancer prevention : APJCP, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06758739 (Comparison of Curcumin and Intralesional Steroids in Oral Submucous Fibrosis), which is not on this map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06758739 phase3not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Comparison of Curcumin and Intralesional Steroids in Oral Submucous Fibrosis

TypeinterventionalSponsorServices Institute of Medical Sciences, PakistanRan2025 to 2025Enrolled70ConditionsOral Submucous FibrosisArmsCurcumin (Turmeric), Intralesional Steroid Injection
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Interventions for managing oral submucous fibrosis.The Cochrane database of systematic reviews · 2024
    Pooled it
  2. Genetic diversity and camphor profiling ofFrontiers in pharmacology · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. The Therapeutic Effects of Curcumin on Oral Disease: A Systematic Review.Clinical pharmacology : advances and applications · 2025
    Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ankita BohraDepartment of Oral Medicine and Radiology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai- 600077, Tamil Nadu, India.
T N Uma MaheswariDepartment of Oral Medicine and Radiology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai- 600077, Tamil Nadu, India.
Aditya HarshDepartment of Oral and Maxillofacial Surgery, Vyas Dental College and Hospital, Jodhpur, Rajasthan, India.
Ayush GargDepartment of Oral and Maxillofacial Surgery, Mahatma Gandhi Dental College and Hospital, Sitapura, Jaipur, India.
Mahatma Gandhi Dental College & Hospital · INRajasthan Dental College and Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo determine the therapeutic efficacy of Kali haldi in the management of Oral submucous Fibrosis (OSMF) v/s steroid therapy. MATERIALS AND

methodsA clinical prospective study was conducted on 42 patients of oral submucous fibrosis were equally divided into 2 groups. Group A patients were treated with a mixture of powdered Kali Haldi and aloe vera gel in equal ratio 3 times a day for 3 months. Group B patients were treated with intralesional injection of hydrocortisone and hyaluronidase for 6 weeks with oral antioxidant supplements for 3 months. Burning sensation, cheek flexibility, mouth opening, and tongue protrusion were evaluated before, during, and after treatment at an interval of 15 days, 1 month, 2, month and 3 months.

resultsStatistically significant results were obtained at the end of 3 months duration for both the groups (P < 0.001). The Symptomatic correction was more evident in the case of Group A patients than Group B. Response of the ayurvedic regimen was potentially better as compared to the regular steroid therapy.

conclusionThe study concludes that Combination therapy works wonders in the case of OSMF in stages I, II, III and can be a good option, comparatively safe and with negligible side effects, but potent and equally effective management of oral submucous fibrosis. Henceforth, it will be better to do such kinds of studies on a vast scale including larger samples and longer duration to check the efficacy and durability of this ancient ayurvedic regimen.

Indexed as

AntioxidantsComplex MixturesCurcumaDietary SupplementsDrug Therapy, CombinationHumansHyaluronoglucosaminidaseHydrocortisoneInjections, IntralesionalMedicine, AyurvedicOral Submucous FibrosisPlant ExtractsPlant PreparationsProspective StudiesTreatment OutcomeAloe vera gelAntioxidantsComplex MixturesHyaluronoglucosaminidaseHydrocortisonePlant ExtractsPlant Preparationsturmeric extractAloe veraAntioxidantayurvedic managementOral submucous fibrosis

Identifiers

PMID34967575
PMCPMC9080373
OpenAlexW4200184605

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.